From: The effect of COVID-19 on prostate cancer testing in Australia
Average 2015–2019 (95%CI) | 2020 | Difference (95%CI; and % of average) | Significance | |
---|---|---|---|---|
PSA tests | 181,056 (175,425 to 185,379) | 167,426 | − 13,629 (8671–18,588; 92) | P = 0.002 (t = 7.63) |
Prostate MRI* | 9826† | 8683 | − 1143 (‡; 88) | N/A‡ |
Prostate biopsies | 5101 (4730–5906) | 5201 | + 100 (− 472 to 672; 102) | P = 0.653 (t = − 0.49) |